Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival

Gynecologic Oncology

Volumn 65, Issue 3, 1997, Pages 425-429

  Johnson, Gary A ^a   Mannel, Robert ^a   Khalifa, Mahmoud ^c   Walker, Joan L ^a   Wren, Mary ^c   Min, Kyung Whan ^b   Benbrook, Doris M ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b Deaconess Hospital Oklahoma City   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; PRIORITY JOURNAL; RECEPTOR DENSITY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR BIOPSY; VULVA CARCINOMA; VULVECTOMY;

EID: 0031172256     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4660     Document Type: Article

References (48)

1. 1. Seshadri R, McLeay WR, Horsfall DJ, McCaul K: Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer. Int J Cancer 69:23-27, 1996
2. 2. Mellon K, Wright C, Kelly P, Horne CH, Neal DE: Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 153:919-925, 1995
3. 3. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F, Milano G: Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11:1873-1878, 1993
4. 4. Veale D, Kerr N, Gibson GJ, Kelly PJ, Harris AL: The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br J Cancer 68:162-165, 1993
5. 5. Berchuck A, Rodriguez GC, Kamek A, Dodge RK, Soper JT, Clarke-Pearson DL, Bast RC: Epidermal growth factor expression in normal ovarian epithelium and ovarian cancer. Am J Obstet Gynecol 164:669-674, 1991
6. 6. Khalifa MA, Abdoh AA, Mannel RS, Haraway SD, Walker JL, Min K-W: Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma. Cancer 73:370-376, 1994
7. 7. van Dam PA, Lowe DG, Watson JV, James M, Chard T, Hudson CN, Shepherd JH: Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erB-2 oncoprotein in normal and neoplastic tissues of the female genital tract. Gynecol Oncol 42:256-264, 1991
8. 8. Berchuck A, Rodriguez G, Kamel A, Soper JT, Clarke-Pearson DL, Bast RC Jr: Expression of epidermal growth factor receptor and HER-2/Neu and in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol 76:381-387, 1990
9. 9. Pfeiffer D, Stellwag B, Pfeiffer A, Borlinghaus P, Meier W, Scheidel P: Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol Oncol 33:146-150, 1989
10. 10. Hale RJ, Buckley CH, Gullick WJ, Fox H, Williams J, Wilcox FL: Prognostic value of epidermal growth factor receptor expression in cervical carcinoma. J Clin Pathol 46:149-153, 1993
11. 11. Berchuck A, Soisson AP, Olt GJ, Soper JT, Clarke-Pearson DL, Bast RC, McCarty KS: Epidermal growth factor expression in normal and malignant endometrium. Am J Obstet Gynecol 161:1247-1252, 1989
12. 12. Lombardero J, Perez R, Skoog L: Synergistic inhibitory effect of gamma-interferon and EGF on A431 cells. Anticancer Res 12:201-204, 1992
13. 13. Carter TH, Kung HJ: Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor. Crit Rev Oncogen 5:389-428, 1994
14. 14. Chapman WB, Lorincz AT, Willett GD, Wright VC, Kurman RJ: Epidermal growth factor receptor expression and the presence of human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynecol Pathol 11:221-226, 1992
15. 15. Sherwood ER, Lee C: Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. World J Urol 13:290-296, 1995
16. 16. Bigsby RM, Aixin L, Bomalaski J, Stehman FB, Look KY, Sutton GP: Immunohistochemical study of HER-2/new, epidermal growth factor receptor and steroid receptor expression in normal and malignant endometrium. Obstet Gynecol 79:95-100, 1992
17. 17. Yamada K, Iwai K, Okada Y, Mori M: Immunohistochemical expression of epidermal growth factor receptor in salivary gland tumours. Virchows Arch A Pathol Anat 415:523-531, 1989
18. 18. Tervahauta A, Syrjanen S, Syrjanen K: Epidermal growth factor receptor expression in human papillomavirus lesions of the uterine cervix. Int J Gynecol Pathol 13:234-240, 1994
19. 19. Hayashi Y, Hachisuga T, Iwasaka T, Fukuda K, Okuma Y, Yokoyama M, Sugimori H: Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol 40:147-151, 1991
20. 20. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi H, Angeletti CA, Pingitore R, Pepe S, Basolo F, Bevilacqua G: Epidermal growth factor receptor (EGF-R) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur J Cancer 31:178-183, 1995
21. 21. Kerr LD, Holt JT, Matrisian LM: Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242:1424-1427, 1988
22. 22. Matrisian L, Bowden T: Stromelysin/transin and tumor progression. Semin Cancer Biol 1:107-115, 1990
23. 23. Wells A: The epidermal growth factor receptor and its ligands. Cancer Treat Res 47:143-168, 1989
24. 24. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R: Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 164:997-1004, 1991
25. 25. Stehman FB, Bundy BN, Ball H, Clarke-Pearson DL: Sites of failure and times to failure in carcinoma of the vulva treated conservatively: A Gynecologic Oncology Group study. Am J Obstet Gynecol 174:1128-1133, 1996
26. 26. DiSaia PJ, Creasman WT: Clinical Gynecologic Oncology, St. Louis, MO, Mosby Year Book, 1993, 4th ed, p 37
27. 27. Shin DM, Ro JY, Hong WK, Hittelman WN: Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:3153-3159, 1994
28. 28. Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J, Dmitrovsky E: Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 53:2379-2380, 1993
29. 29. Rao JY, Hemstreet GP III, Hurst RE, Bonner RB, Jones PL, Min K-W, Fradet Y: Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis. Proc Natl Acad Sci USA 90:8287-8291, 1993
30. 30. Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579-3584, 1993
31. 31. Hording U, Junge J, Daugaard S, Lunfvall F, Poulsen H, Bock JE: Vulval squamous cell carcinomas and papillomavirus: Indications for two different aetiologies. Gynecol Oncol 52:241-244, 1994
32. 32. Pilotti S, Donghi R, D'Amato L, Giaroloa M, Longoni A, Torre GD, DePalo G, Pierotti MA, Rilke F: Papillomavirus, p53 alteration and primary carcinoma of the vulva. Eur J Cancer 29:924-925, 1993
33. 33. Lee YYL, Wilczynski SP, Chumakov A, Chih D, Koefler HP: Carcinoma of the vulva: HPV and p53 mutations. Oncogene 9:1655-1659, 1994
34. 34. Monk BJ, Burger RA, Lin F, Parham G, Vasilev SA, Wilczynski SP: Prognostic significance of human papilloma virus DNA in vulvar carcinoma. Obstet Gynecol 85:709-715, 1995
35. 35. Homesley HD, Bundi BN, Sedlis A, Yardan E, Berek JS, Jahshan A: Assessment of current international federation of gynecology and obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a GOG Group study). Am J Obstet Gynecol 164:997-1004, 1991
36. 36. Mendelsohn J: Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. J Natl Cancer Inst Monographs 13:125-131, 1992
37. 37. Lee M, Draoui M, Zia F, Gazdar A, Olie H, Bepler G, Bellot F, Tarr C, Kris R, Moody TW: Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines. Monographs Natl Cancer Inst 13:117-123, 1992
38. 38. Perez-Soler R, Donate NJ, Shin DM, Rosenblum MG, Zhang HZ, Tornos C, Brewer H, Chan SC, Lee JS, Hong WK: Tumor epidermal growth factor receptor studies in patients with non-small cell lung cancer or head and neck cancer treated with monoclonal antibody RG83852. J Clin Oncol 12:730-739, 1994
39. 39. Modjtahedi H, Hickish T, Nicolson M, Moore J, Styles J, Eccles S, Jackson E, Salter J, Sloane J, Spencer L, Priest K, Smith I, Dean C, Gore M: Phase I trial and tumour localisation of the anti-EGF-R monoclonal antibody ICR62 in head and neck or lung cancer. Br J Cancer 73:228-235, 1996
40. 40. Goss GD, McBurney MW: Physiological and clinical aspects of vitamin A and its metabolites. Crit Rev Clin Lab Sci 29:185-215, 1992
41. 41. Smith MA, Parkinson DR, Cheson BC, Friedman MA: Retinoids in cancer therapy. J Clin Oncol 10:839-864, 1992
42. 42. Semba RD: Vitamin A, immunity and infection. Clin Infect Dis 19:489-499, 1994
43. 43. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB: Antagonistic actions of retinoic acid and dexamethasone on anchorage independent growth and epidermal growth factor binding of normal rat kidney cells. Cancer Res 44:1635-1641, 1984
44. 44. Chen JK, Li L, Mioh H: Differential responsiveness of normal and simian virus 40-transformed BALB/c 3T3 cell to retinoic acid: rapid enhancement of epidermal growth factor receptor binding in a simian virus 40-3T3 variant. Cancer Res 47:4995-4999, 1987
45. 45. Zheng ZS, Goldsmith LA: Modulation of epidermal growth factor receptors by retinoic acid in ME180 cells. Cancer Res 50:1201-1205, 1990
46. 46. Piazza GA, Ritter JL: Involvement of transforming growth factor-alpha and its receptor in the growth response of cultured human epidermal cells to retinoic acid. Epithel Cell Biol 2:170-175, 1993
47. 47. Grandis JR, Zeng A, Tweardy DJ: Retinoic acid normalizes the increased gene transcription rate of TGF-α and EGF-R in head and neck cancer cell lines. Nat Med 2:237-240, 1995
48. 48. Hong WK, Itri LM: Retinoids and Human Cancer, in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids. New York, Raven Press, 1994, pp 597-630